We are live on
!
Find out more
Mackenzie Financial Portfolio holdings
AUM
$83.3B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+7.5%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$69.4B
AUM Growth
+$3.09B
(+4.7%)
Cap. Flow
-$1.1B
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
21.76%
Holding
1,637
New
142
Increased
674
Reduced
560
Closed
116
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$313M |
| 2 |
Visa
V
|
+$211M |
| 3 |
Brookfield Asset Management
BAM
|
+$201M |
| 4 |
Roper Technologies
ROP
|
+$103M |
| 5 |
Gartner
IT
|
+$82.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$417M |
| 2 |
ON Semiconductor
ON
|
+$286M |
| 3 |
AYX
Alteryx Inc
AYX
|
+$140M |
| 4 |
Bank of Montreal
BMO
|
+$128M |
| 5 |
Toronto Dominion Bank
TD
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.36% |
| 2 | Technology | 19.76% |
| 3 | Industrials | 13.24% |
| 4 | Healthcare | 9.04% |
| 5 | Energy | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Rocket Lab Corp
RKLB
$40.6B
| $57K | ﹤0.01% |
13,863
| – | – |
|
1477
Pacific Biosciences
PACB
$435M
| $56.6K | ﹤0.01% |
15,090
| – | – |
|
1478
Aurora
AUR
$12.6B
| $53.9K | ﹤0.01% |
+19,096
| New | +$54.8K |
|
1479
Upland Software
UPLD
$12.8M
| $53.4K | ﹤0.01% |
1,729
+603
| +54% | +$21.8K |
|
|
BDN
1480
Brandywine Realty Trust
BDN
$524M
| $53.3K | ﹤0.01% |
11,106
-12,100
| -52% | -$56.1K |
|
1481
Porch Group
PRCH
$1.64B
| $50.9K | ﹤0.01% |
+11,811
| New | +$35.2K |
|
1482
Aldeyra Therapeutics
ALDX
$92.9M
| $50.7K | ﹤0.01% |
+15,517
| New | +$51K |
|
1483
Pitney Bowes
PBI
$2.4B
| $49.1K | ﹤0.01% |
11,341
-80,674
| -88% | -$333K |
|
1484
Spero Therapeutics
SPRO
$67.7M
| $48.9K | ﹤0.01% |
28,442
+6,980
| +33% | +$10.9K |
|
1485
Nordic American Tanker
NAT
$1.38B
| $48.6K | ﹤0.01% |
12,394
| – | – |
|
1486
Sabre
SABR
$731M
| $48.4K | ﹤0.01% |
20,001
| – | – |
|
|
MAXN
1487
DELISTED
Maxeon Solar Technologies
MAXN
| $48.4K | ﹤0.01% |
+145
| New | +$65.2K |
|
1488
Organogenesis Holdings
ORGO
$305M
| $47.3K | ﹤0.01% |
16,650
+2,859
| +21% | +$9.72K |
|
|
QIPT
1489
DELISTED
Quipt Home Medical
QIPT
| $46.2K | ﹤0.01% |
+10,575
| New | +$47.8K |
|
|
ESPR
1490
DELISTED
Esperion Therapeutics
ESPR
| $46.1K | ﹤0.01% |
17,218
+3,827
| +29% | +$9.3K |
|
1491
Akebia Therapeutics
AKBA
$354M
| $45.3K | ﹤0.01% |
24,739
+1,580
| +7% | +$2.53K |
|
1492
ThredUp
TDUP
$746M
| $43.5K | ﹤0.01% |
21,773
+6,361
| +41% | +$13K |
|
1493
CytomX Therapeutics
CTMX
$675M
| $39.5K | ﹤0.01% |
18,138
-1,541
| -8% | -$2.84K |
|
|
NKLA
1494
DELISTED
Nikola Corporation Common Stock
NKLA
| $39.4K | ﹤0.01% |
1,262
| – | – |
|
1495
Ring Energy
REI
$315M
| $38.8K | ﹤0.01% |
+19,794
| New | +$29.5K |
|
1496
Conduent
CNDT
$244M
| $37.7K | ﹤0.01% |
11,154
| – | – |
|
|
CDTX
1497
DELISTED
Cidara Therapeutics
CDTX
| $36.1K | ﹤0.01% |
1,965
+702
| +56% | +$10.1K |
|
1498
Opko Health
OPK
$985M
| $31K | ﹤0.01% |
25,843
| – | – |
|
1499
Clean Energy Fuels
CLNE
$427M
| $30.1K | ﹤0.01% |
11,245
| – | – |
|
|
SGMO
1500
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $29.4K | ﹤0.01% |
43,920
-29,879
| -40% | -$21.7K |
|
Similar funds
Mackenzie Financial's Q1 2024 Portfolio in Review
As of Q1 2024, Mackenzie Financial held 1,637 positions worth $69.4B, up 4.7% from $66.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Mackenzie Financial's Q1 2024 filing shows 142 new, 674 increased, 560 reduced and 116 closed positions. Its largest new stake was Cognex: 1,284,682 shares worth $54.5M. The largest sale was Synopsys, an estimated $417M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.
- Mackenzie Financial's largest Q1 2024 buy was Cognex: 1,284,682 shares worth $54.5M.
- Mackenzie Financial added most to Cadence Design Systems in Q1 2024, an estimated $313M increase.
- Mackenzie Financial's biggest Q1 2024 reduction was Synopsys, cutting an estimated $417M.
- Mackenzie Financial fully exited Alteryx Inc in Q1 2024, selling an estimated $140M.
- Mackenzie Financial's ten largest holdings make up 22% of its $69.4B portfolio in Q1 2024.
- Mackenzie Financial opened 142 new positions and closed 116 in Q1 2024.
- Mackenzie Financial's portfolio value rose 4.7% quarter-over-quarter to $69.4B.
Based on Mackenzie Financial's 13F filing for Q1 2024, filed 10 May 2024.